# Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.

> **NCT04958291** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 25 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CC-99677
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04958291
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-03
- **Primary completion:** 2021-12-06
- **Final completion:** 2021-12-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04958291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04958291, "Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04958291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*